Resmed (RMD) Restructuring Costs (2015 - 2025)

Resmed has reported Restructuring Costs for 10 years, with the latest figure at $5.9 million in Q4 2025.

• For the quarter ending Q4 2025, Restructuring Costs changed N/A year-over-year to $5.9 million; the trailing twelve-month figure through Mar 2026 stood at $23.7 million (up 84653.57% YoY), and the FY2025 full-year result was $2.0 million, down 96.84% from the prior year.
• Restructuring Costs for Q4 2025 stood at $5.9 million, down from $15.8 million in the prior quarter.
• The five-year high for Restructuring Costs was $15.8 million in Q3 2025, with the low at -$8.7 million in Q2 2021.
• Historically, Restructuring Costs has averaged $4.0 million across 4 years, with a median of $4.0 million in 2025.
• Annual changes were most pronounced in 2024 — Restructuring Costs plunged 99.69% — and 2025, when it surged 7153.57%.
• Resmed's Restructuring Costs stood at -$8.7 million in 2021, then jumped by 205.81% to $9.2 million in 2023, then sank by 99.69% to $28000.0 in 2024, then jumped by 20971.43% to $5.9 million in 2025.
• The last three Restructuring Costs figures came in at $5.9 million (Q4 2025), $15.8 million (Q3 2025), and $2.0 million (Q2 2025), per Business Quant data.